Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiology to functionality: the brain and neurotransmitter activity.

G Racagni1, N Brunello

  • 1Centre of Neuropharmacology, University of Milan, Italy.

International Clinical Psychopharmacology
|September 1, 1999
PubMed
Summary

The monoamine hypothesis of depression suggests a deficit in serotonin or noradrenaline. New selective noradrenaline reuptake inhibitors are advancing our understanding of this neurotransmitter

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglial diversity along the hippocampal longitudinal axis impacts synaptic plasticity in adult male mice under homeostatic conditions.

Journal of neuroinflammation·2022
Same author

Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade.

Frontiers in pharmacology·2021
Same author

Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.

Cardiovascular diabetology·2020
Same author

Lymnaea stagnalis as model for translational neuroscience research: From pond to bench.

Neuroscience and biobehavioral reviews·2019
Same author

Modulation of neuroplasticity-related targets following stress-induced acute escape deficit.

Behavioural brain research·2019
Same author

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Pharmacological reviews·2018

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The monoamine hypothesis of depression links depression to deficiencies in serotonin and noradrenaline.
  • Selective serotonin reuptake inhibitors (SSRIs) have significantly advanced understanding of serotonin's role.
  • Limited understanding of noradrenaline's role persisted due to a lack of specific agents.

Purpose of the Study:

  • To explore the role of noradrenaline in depression.
  • To examine the impact of selective noradrenaline reuptake inhibitors (SNRIs).
  • To understand the neuroanatomical pathways and receptor interactions involved in monoamine-based depression treatments.

Main Methods:

  • Review of clinical and experimental evidence.
  • Analysis of neuroanatomy, focusing on serotonergic and noradrenergic pathways to the prefrontal cortex.

Related Experiment Videos

  • Examination of the effects of selective reuptake inhibitors on neurotransmitter levels and receptor activity.

    • Main Results:

    • Selective serotonin reuptake inhibitors (SSRIs) have clarified serotonin's role in depression.
    • The development of selective noradrenaline reuptake inhibitors (SNRIs) like reboxetine is refocusing attention on noradrenaline.
    • Modulating monoamine levels impacts multiple pathways and receptors, leading to diverse effects.

    Conclusions:

    • Noradrenaline's role in depression is gaining renewed focus with the availability of SNRIs.
    • Understanding the complex interactions of monoamine pathways and receptors is crucial for predicting treatment outcomes.
    • Further research into intracellular responses is ongoing, aided by selective antidepressants.